|
產品描述： Enfuvirtide (T20;DP178) is an anti-HIV-1 fusion inhibitor peptide. |
|
靶點：
HIV-1;HIVProtease |
體內研究：
Enfuvirtide has a T1/2 of 3.8 h |
參考文獻：
1. Figueira TN, et al. Quantitative analysis of molecular partition towards lipid membranes using surface plasmon resonance. Sci Rep. 2017 Mar 30;7:45647. 2. Cao P, et al. The improved efficacy of Sifuvirtide compared with Enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance. PLoS One. 2017 Feb 16;12(2):e0171567. 3. Wang X, et al. IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages. Front Immunol. 2017 Mar 6;8:210. |
|
溶解性：
DMSO : 20 mg/mL (4.45 mM; Need ultrasonic) H2O : 0.67 mg/mL (0.15 mM; Need ultrasonic) |
|
保存條件：
-20°C |
配置溶液濃度參考：
|
1mg |
5mg |
10mg |
| 1 mM |
0.223 ml |
1.113 ml |
2.226 ml |
| 5 mM |
0.045 ml |
0.223 ml |
0.445 ml |
| 10 mM |
0.022 ml |
0.111 ml |
0.223 ml |
| 50 mM |
0.004 ml |
0.022 ml |
0.045 ml |
|
| 注意： |
部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
危險品化學品經營許可證（不帶存儲）
營業執照(三證合一)
北京